Lakeshore Hospital - Unlisted Shares
Fundamentals
- Current Price
- ₹0
- Market Cap
- 0
- ISIN
- INE01TI01010
- Face Value
- ₹10
- P/E Ratio
- 0
- EPS
- ₹3.9
- P/B Ratio
- 0
- Book Value
- 42.22
- Debt / Equity Ratio
- 0.00
Key Financials
Profit & Loss
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue from Operations | 407.52 | 396.22 | 419.18 | 358.59 | 242.31 |
| Growth % | 2.85% | -5.48% | 16.90% | 47.99% | - |
| Operating Expenses | 336.63 | 323.26 | 317.32 | 276.84 | 210.69 |
| Growth % | 4.14% | 1.87% | 14.62% | 31.40% | - |
| Operating Profit | 70.89 | 72.96 | 101.86 | 81.74 | 31.62 |
| Op. Profit Margin % | 17.40% | 18.41% | 24.30% | 22.80% | 13.05% |
| Other Income | 8.23 | 6.67 | 5.36 | 3.07 | 2.10 |
| Finance Cost | 0.33 | 0.93 | 2.11 | 2.57 | 3.60 |
| Depreciation | 26.05 | 23.70 | 22.69 | 21.46 | 20.32 |
| Profit Before Tax | 52.74 | 55.00 | 82.41 | 60.78 | 9.80 |
| Tax | 13.62 | 11.13 | 24.90 | 17.90 | 2.08 |
| Tax % | 25.83% | 20.23% | 30.21% | 29.45% | 21.20% |
| Profit After Tax | 39.12 | 43.87 | 57.52 | 42.88 | 7.72 |
| Growth % | 10.83% | 23.72% | 34.14% | 455.24% | - |
| PAT % | 9.60% | 11.07% | 13.72% | 11.96% | 3.19% |
| Diluted EPS | 3.91 | 4.39 | 5.75 | 4.29 | 0.77 |
Company Financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Equity Capital | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Other Equity | 322.24 | 300.22 | 273.45 | 231.21 | 194.66 |
| Total Equity | 422.24 | 400.22 | 373.45 | 331.21 | 294.66 |
| Borrowings | 0.00 | 0.00 | 7.24 | 13.01 | 29.14 |
| Other Non-Current Liabilities | 39.53 | 38.83 | 38.37 | 43.38 | 22.44 |
| Total NC Liabilities | 39.53 | 38.83 | 45.61 | 56.39 | 51.58 |
| Borrowings | 0.00 | 0.03 | 5.79 | 5.79 | 8.07 |
| Other Current Liabilities | 71.53 | 68.60 | 75.41 | 70.55 | 72.46 |
| Total Current Liabilities | 71.53 | 68.63 | 81.20 | 76.34 | 80.54 |
| Equity + Liabilities | 533.30 | 507.68 | 500.26 | 463.94 | 426.78 |
| Fixed Assets (incl. WIP) | 346.94 | 347.85 | 333.32 | 340.66 | 339.36 |
| Other Non Current Assets | 25.21 | 36.20 | 24.03 | 32.80 | 16.07 |
| Total NC Assets | 372.15 | 384.05 | 357.35 | 373.47 | 355.43 |
| Trade Receivables | 33.93 | 26.87 | 19.99 | 20.13 | 18.14 |
| Cash & Cash Equivalents | 106.33 | 76.66 | 98.41 | 11.62 | 38.17 |
| Other Current Assets | 20.88 | 20.10 | 24.51 | 58.72 | 15.04 |
| Total Current Assets | 161.15 | 123.63 | 142.91 | 90.48 | 71.35 |
| Total Assets | 533.30 | 507.68 | 500.26 | 463.94 | 426.78 |
Shareholding Pattern
- Mr. Shamsheer Vayalil Parambath
- 42.62%
- Mr. Yusuff Ali M A
- 18.80%
- Others
- 38.58%
Strengths & Weaknesses
Strengths
- Strong Financial Performance: In FY 2024–25, the company reported a total income of ₹407.52 crores and a net profit of ₹39 crores, reflecting solid profitability despite industry challenges.
- Growing Patient Base: The hospital served 3,38,651 out-patients and 21,022 in-patients during the year. Additionally, it treated 18,820 foreign out-patients and 373 foreign in-patients, highlighting its strong international appeal and medical tourism growth
- Service Diversification Across Specialties: Key revenue drivers included Nephrology, Medical Oncology, Neuro Surgery, Gastroenterology, Cardiology, GI Surgery, and Orthopaedics. The Kozhikode Medical Centre alone saw 28,000 patients, up from 24,000 in the prior year, a growth of ~17%.
- CSR and Community Impact: The company spent ₹89 lakhs on CSR projects, in addition to ₹17.37 lakhs from prior earmarked funds. It also provided ₹14.85 crores worth of concessions to economically weaker patients, reinforcing its commitment to social responsibility
Weaknesses
- Pending Litigations and Legal Risks: The company is involved in multiple litigations, including arbitration cases and disputes related to taxation and employee benefits. Although management believes they will not materially impact operations, these pose a potential financial and reputational risk.
- Decline in Foreign Exchange Earnings: Foreign exchange earnings dropped to ₹8.94 crores in FY 2024–25 from ₹14.47 crores in the previous year, while outgo was ₹3.37 crores (vs. ₹28.78 crores prior year). This volatility suggests pressure in international operations and medical tourism
About Lakeshore Hospital
Lakeshore Hospital and Research Centre Limited was incorporated in 1996 in Kochi, Kerala as a public limited company.
Board of Directors
- Dr Vayalil Parambath Shamsheer - Chairman
- Mr K N Prabhakaran Nair - Director
- Dr K V Johny - Director
- Mr P D Mathew - Director
- Mr M M Mathai - Director
- Mr Job Varghese - Director
- Dr K Chithrathara - Director
- Mr V Venugopal - Independent Director
- Mr Reuben Joseph - Independent Director
Senior Management
- Mr Jayesh V Nair - CHIEF EXECUTIVE OFFICER
- Mr Gireesh Kumar E - CHIEF FINANCIAL OFFICER
- Mr R Muraleedharan - COMPANY SECRETARY